ASD ETF (Defiance Autism Impact ETF) is managed by Defiance ETFs, LLC with $1.3M in net assets. ASD expense ratio is 0.79%, sectors including Unknown, Health Care, Consumer Discretionary. Inception date: 2026-06-01.

ASD performance shows data across multiple time periods.. ASD dividend yield stands at 0.02%, paid quarterly.

ASD top holdings include Definium Therapeutics Inc. (4.4%), Acadia Healthcre (3.3%), Lifestance Health Group Inc (3.1%), Neuren Pharmaceuticals Ltd. (3.1%), Otsuka Holdings Co., Ltd. (3.1%). View all ASD holdings, sector breakdown, or dividend history.

ASD can be compared against other funds using the overlap calculator or side-by-side comparison tool. ASD alternatives are available via the screener, along with tax-loss harvesting opportunities.